Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in Participants With Bipolar I Depression

ClinicalTrials.gov ID: NCT02670551

Public ClinicalTrials.gov record NCT02670551. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 7:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Fixed-Dose Clinical Trial Evaluating The Efficacy, Safety And Tolerability Of Cariprazine In Patients With Bipolar I Depression

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study investigates the efficacy of a fixed-dose regimen of cariprazine 1.5 milligram (mg)/day or 3 mg/day compared to placebo for treatment of the depressive episode in participants with bipolar I disorder. The safety and tolerability of the fixed-dose regimens will be evaluated.

Study identification

NCT ID
NCT02670551
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Forest Laboratories
Industry
Enrollment
488 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 16, 2016
Primary completion
Jul 18, 2017
Completion
Jul 18, 2017
Last update posted
Jan 29, 2019

2016 – 2017

United States locations

U.S. sites
44
U.S. states
19
U.S. cities
42
Facility City State ZIP Site status
Arkansas Psychiatric Clinic Clinical Research Trials PA Little Rock Arkansas 72211
ATP Clinical Research, Inc. Costa Mesa California 92626
Synergy San Diego Escondido California 92025
Integrated Medical and Behavioral Associates Glendale California 91204
Apostle Clinical Trials, Inc. Long Beach California 90813
Pacific Research Partners, LLC Oakland California 94612
Artemis Institute for Clinical Research San Diego California 92103
Schuster Medical Research Institute Sherman Oaks California 91403
Viking Clinical Research Temecula California 92591
Pacific Clinical Research Medical Group Upland California 91786
Comprehensive Psychiatric Care Norwich Connecticut 06360
CNS Healthcare Jacksonville Florida 32256
Clinical Neuroscience Solutions, Inc Orlando Florida 32801
Olympian Clinical Research Tampa Florida 33609
Radiant Research Atlanta Georgia 30328
iResearch Atlanta, LLC Decatur Georgia 30030
Northwest Behavioral Research Center Marietta Georgia 30060
Carman Research Smyrna Georgia 30080
Psychiatric Medicine Associates, L.L.C Skokie Illinois 60076
Neuroscience Research Institute Inc. Winfield Illinois 60190
St. Charles Psychiatric Associates - Midwest Research Group Saint Charles Missouri 63304
Altea Research Institute Las Vegas Nevada 89102
Hassman Research Institute Berlin New Jersey 08009
Neurobehavioral Research, Inc. Cedarhurst New York 11516
Medical & Behavioral Health Research, PC New York New York 10023
Neuro-Behavioral Clinical Research Canton Ohio 44718
Patient Priority Clinical Sites Cincinnati Ohio 45215
Ohio State University Department of Psychiatry Columbus Ohio 43210
Midwest Clinical Research Center Dayton Ohio 45417
IPS Research Company Oklahoma City Oklahoma 73103
Sooner Clinical Research Oklahoma City Oklahoma 73112
Oregon Center for Clinical Investigations, Inc. Portland Oregon 97214
Oregon Center for Clinical Investigations Salem Oregon 97301
Lehigh Center for Clinical Research Allentown Pennsylvania 18104
Lincoln Research, LLC Lincoln Rhode Island 02865
Clinical Neuroscience Solutions Memphis Tennessee 38119
Red Oak Psychiatry Associates, PA Houston Texas 77090
Houston Clinical Trials, LLC Houston Texas 77098
Research Across America Plano Texas 75093
Family Psychiatry of The Woodlands The Woodlands Texas 77381
Alliance Research Group Richmond Virginia 23230
Northwest Clinical Research Center Bellevue Washington 98007
Core Clinical Research Kirkland Washington 98033
Summit Research Network Seattle Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 30 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02670551, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 29, 2019 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02670551 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →